ResMed, Inc. focuses on developing, manufacturing, and marketing products for respiratory disease management, particularly sleep-disordered breathing. Its net sales are divided into medical devices (50.4%), masks (37.9%), and software as a service (11.7%), with the U.S. contributing 61.4% of total sales. The company operates six production sites across the U.S., Australia, China, Singapore, and Malaysia.